Gold nanoparticle-based drug delivery platform for antineoplastic chemotherapy

Current Drug Metabolism

Volumn 15, Issue 6, 2014, Pages 620-631

  Liang, Juan Juan ^a   Zhou, Ying Ying ^a   Wu, Jun ^b   Ding, Ya ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Conjugates; Drug delivery system; Gold nanoparticles; Toxicity

Indexed keywords

ANTINEOPLASTIC AGENT; GLUTATHIONE; GOLD NANOPARTICLE;

ARTICLE; CANCER CHEMOTHERAPY; DRUG ABSORPTION; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG METABOLISM; HUMAN; HYDROPHOBICITY; LIGHT; NANOPHARMACEUTICS; PH; QUANTITATIVE STRUCTURE PROPERTY RELATION; STATIC ELECTRICITY; SURFACE PROPERTY;

EID: 84908579587     PISSN: 13892002     EISSN: 18755453     Source Type: Journal    
DOI: 10.2174/1389200215666140605131427     Document Type: Article

References (109)

1. Allen, T. M.; Cullis, P. R. Drug delivery systems: entering the mainstream. Science, 2004, 303, 1818-1822.
2. Sinha, R.; Kim, G. J.; Nie, S.; Shin, D. M. Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery. Mol. Cancer Ther., 2006, 5(8), 1909-1917.
3. Farokhzad, O. C.; Langer, R. Impact of nanotechnology on drug delivery. Acs nano, 2009, 3(1), 16-20.
4. Han, M.; He, C. X.; Fang, Q. L.; Yang, X. C.; Diao, Y. Y.; Xu, D. H.; He, Q. J.; Hu, Y. Z.; Liang, W. Q.; Yang, B.; Gao, J. Q. A novel camptothecin derivative incorporated in nano-carrier induced distinguished improvement in solubility, stability and anti-tumor activity both in vitro and in vivo. Pharm. Res., 2009, 26(4), 926-935.
5. Wu, J; Chu, C. C. Water insoluble cationic poly(ester amide)s: synthesis, characterization and applications. J. Mater. Chem. B, 2013, 1, 353-360.
6. Huang, X.; Brazel, C. S. On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J. Control. Release, 2001, 73(2-3), 121-136.
7. Kataoka, K.; Harada, A.; Nagasaki, Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv. Drug Deliv. Rev., 2001, 47(1), 113-131.
8. Torchilin, V. P. Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug Discov., 2005, 4, 145-160.
9. Panyam, J.; Labhasetwar, V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev., 2003, 55(3), 329-347.
10. Liu, Z.; Chen, K.; Davis, C. Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Res., 2008, 68, 6652-6660.
11. Jang, H. R.; Oh, H.-J.; Kim, J.-H.; Jung, K. Y. Synthesis of mesoporous spherical silica via spray pyrolysis: Pore size control and evaluation of performance in paclitaxel pre-puri cation. Microporous Mesoporous Mater., 2013, 165, 219-227.
12. Chakravarthy, K. V.; Davidson, B. A. Doxorubicin-conjugated quantum dots to target alveolar macrophages and inflammation. Nanomedicine, 2011, 7, 88-96.
13. Daniel, M. C.; Astruc, D. Gold nanoparticles: Assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem. Rev., 2004, 104 (1), pp 293-346.
14. Liao, C.; Sun, Q.; Liang, B.; Shen, J.; Shuai, X. Targeting EGFRoverexpressing tumor cells using Cetuximab-immunomicelles loaded with doxorubicin and superparamagnetic iron oxide. Eur. J. Radiol., 2011, 80, 699-705.
15. Boisselier, E.; Astruc, D. Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. Chem. Soc. Rev., 2009, 38, 1759-1782.
16. Cheng, Y.; Samia, A. C.; Li, J.; Kenney, M. E.; Resnick, A.; Burda, C. Delivery and efficacy of a cancer drug as a function of the bond to the gold nanoparticle surface. Langmuir, 2010, 26, 2248-2255.
17. Khan, J. A.; Kudgus, R. A.; Szabolcs, A.; Dutta, S.; Wang, E.; Cao, S.; Curran, G. L.; Shah, V.; Curley, S.; Mukhopadhyay, D.; Robertson, J. D.; Bhattacharya, R.; Mukherjee, P. Designing nanoconjugates to effectively target pancreatic cancer cells in vitro and in vivo. PLoS One, 2011, 6(6), e20347.
18. Patra, C. R.; Bhattacharya, R.; Mukhopadhyay, D.; Mukherjee, P. Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer. Adv. Drug Deliv. Rev., 2010, 62, 346-361.
19. Duncan, B.; Kim, C.; Rotello, V. M. Gold nanoparticle platforms as drug and biomacromolecule delivery systems. J. Control. Release, 2010, 148, 122-127.
20. Kumar, A.; Zhang, X.; Liang, X. J. Gold nanoparticles: Emerging paradigm for targeted drug delivery system. Biotechnol. Adv., 2013, 31, 593-606.
21. Marinakos, S. M.; Novak, J. P.; Brousseau III, L. C.; Blaine House, A.; Edeki, E. M.; Feldhaus, J. C.; Feldheim, D. L. Gold particles as templates for the synthesis of hollow polymer capsules. Control of capsule dimensions and guest encapsulation. J. Am. Chem. Soc. 1999, 121, 8518-8522.
22. Sershen, S. R.; Westcott, S. L.; Halas, N. J.; West, J. L. Temperature-sensitive polymer-nanoshell composites for photothermally modulated drug delivery. Biomed. Mater. Res., 2000, 51, 293-298.
23. McIntosh, C. M.; Esposito, E. A.; Boal, A. K.; Simard, J. M.; Martin, C. T.; Rotello, V. M. Inhibition of DNA transcription using cationic mixed monolayer protected gold clusters. J. Am. Chem. Soc., 2001, 123, 7626-7629.
24. Pinto-Alphandary, H.; Aboubakar, M.; Jaillard, D.; Couvreur, P.; Vauthier, C. Visualization of insulin-loaded nanocapsules: in vitro and in vivo studies after oral administration to rats. Pharm. Res., 2003, 20, 1071-1084.
25. Schellenberger, E. A.; Reynolds, F.; Weissleder, R.; Josephson, L. Surface-functionalized nanoparticle library yields probes for apoptotic cells. ChemBioChem. 2004, 5, 275-279.
26. Paciotti, G. F.; Myer, L.; Weinreich, D.; Goia, D.; Pavel, N.; McLaughlin, R. E.; Tamarkin, L. Colloidal gold: A novel nanoparticle vector for tumor directed drug delivery. ChemBioChem., 2004, 5, 275-279.
27. Turkevich, J.; Stevenson, P.; Hillier, J. A study of the nucleation and growth process in the synthesis of colloidal gold. Discuss. Faraday Soc., 1951, 11, 55-75.
28. Kumar, S.; Gandhi, K. S.; Kumar, R. Modeling of formation of gold nanoparticles by citrate method. Ind. Eng. Chem. Res., 2007, 46, 3128-3136.
29. Ding, Y.; Xia, X.-H.; Zhang, C. Synthesis of metallic nanoparticles protected with N, N, N-trimethyl chitosan chloride via a relatively weak affinity. Nanotechnology, 2006, 17, 4156-4162.
30. Jolivet, J.; Cowan, K. H.; Curt, G. A.; Clendeninn, N. J.; Chabner, B. A.; The pharmacology and clinical use of methotrexate. NEMJ., 1983, 309(18), 1094-1104.
31. Chen, Y.-H.; Tsai, C.-Y.; Huang, P.-Y.; Chang, M.-Y.; Cheng, P.-C.; Chou, C.-H.; Chen, D.-H.; Wang, C.-R.; Shiau, A.-L.; Wu, C.-L. Methotrexate conjugated to gold nanoparticles inhibits tumor growth in a syngeneic lungtumor model. Mol. Pharm., 2007, 4(5), 713-722.
32. Baselga, J.; Norton, L.; Albanell, J.; Kim, Y.-M.; Mendelsohn, J. Recombinant humanized anti-HER2 antibody (HerceptinTM) enhances the antitumor activity of Paclitaxel and Doxorubicin against HER2/neu overexpressing human breast cancer xenografts. Cancer Res., 1998, 58, 2825-2831.
33. Mirza, A. Z.; Shamshad, H. Preparation and characterization of doxorubicin functionalized gold nanoparticles. Eur. J. Med. Chem., 2011, 46, 1857-1860.
34. L. Minati; V. Antonini; S. Torrengoa; M. Dalla Serra. Sustained in vitro release and cell uptake of doxorubicin adsorbed onto gold nanoparticles and covered by a polyelectrolyte complex layer. Inter. J. Pharm., 2012, 438, 45-52.
35. Pillay, C. S.; Elliott, E.; Dennison, C. Endolysosomal proteolysis and its regulation. Biochem. J., 2002, 363, 417-429.
36. Akinc, A.; Thomas, M.; Klibanov, A. M.; Langer, R. Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis. J. Gene Med., 2005, 7(5), 657-663.
37. Venkatpurwar, V.; Shiras, A.; Pokharkar, V. Porphyran capped gold nanoparticles as a novel carrier for delivery of anticancer drug: In vitro cytotoxicity study. Inter. J. Pharm., 2011, 409, 314- 320.
38. Dhar, S.; Reddy, E. M.; Shiras, A.; Pokharkar, V.; Prasad, B. L. V. Natural gum reduced/stabilized gold nanoparticles for drug delivery formulations. Chem. Eur. J., 2008, 14, 10244-10250.
39. Dhar, S.; Reddy, E. M.; Prabhune, A. P.; Pokharkar, V.; Shiras, A.; Prasad, B. L. V. Cytotoxicity of sophorolipid-gellan gum-gold nanoparticle conjugates and their doxorubicin loaded derivatives towards human glioma and human glioma stem cell lines. Nanoscale, 2011, 3, 575-580.
40. Kim, C. K.; Ghosh, P.; Pagliuca, C.; Zhu, Z. J.; Menichetti, S.; Rotello, V. M. Entrapment of hydrophobic drugs in nanoparticle monolayers with efficient release into cancer cells. J. Am. Chem. Soc., 2009, 131, 1360-1361.
41. Yang, X. C.; Samanta, B.; Agasti, S. S.; Jeong, Y.; Zhu, Z. J.; Rana, S.; Miranda, O. R.; Rotello, V. M. Drug delivery using nanoparticle-stabilized nanocapsules. Angew. Chem., 2011, 50, 477-481.
42. Meister, A.; Anderson, M. E. Glutathione. Annu. Rev. Biochem., 1983, 52, 711-760.
43. Vina, J.; Saez, G. T.; Wiggins, D.; Roberts, A. F.; Hems, R.; Krebs, H. A. The effect of cysteine oxidation on isolated hepatocytes. Biochem. J., 1983, 212, 39-44.
44. Anderson, M. E. Glutathione: an overview of biosynthesis and modulation. Chem. Biol. Interact., 1998, 111-112, 1-14.
45. Jones, D. P.; Carlson, J. L.; Samiec, P. S.; Sternberg, P.; Mody, V. C.; Reed, R. L.; Brown, L. A. S. Glutathione measurement in human plasma: evaluation of sample collection, storage and derivatization conditions for analysis of dansyl derivatives by HPLC. Clin. Chim. Acta, 1998, 275 (2), 175-184.
46. Rosi, N. L.; Giljohann, D. A.; Thaxton, C. S.; Lytton-Jean, A. K. R.; Han, M. S.; Mirkin, C. A. Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Science, 2006, 312, 1027-1030.
47. Giljohann, D. A.; Seferos, D. S.; Prigodich, A. E.; Patel, P. C.; Mirkin, C. A. Gene regulation with polyvalent siRNA nanoparticle conjugates. J. Am. Chem. Soc., 2009, 131, 2072-2073.
48. Hong, R.; Han, G.; Fernandez, J. M.; Kim, B. J.; Forbes, N. S.; Rotello, V. M. Glutathione-mediated delivery and release using monolayer protected nanoparticle carriers. J. Am. Chem. Soc., 2006, 128, 1078-1079.
49. Pakiari, A. H.; Jamshidi, Z. Nature and strength of M-S bonds (m = Au, Ag, and Cu) in binary alloy gold clusters. J. Phys. Chem. A, 2010, 114, 9212-9221.
50. Bao, Q.-Y.; Geng, D.-D.; Xue, J.-W.; Zhou, G.; Gu, S. Y.; Ding, Y.; Zhang, C. Glutathione-mediated drug release from Tiopronin conjugated gold nanoparticles for acute liver injury therapy. Inter. J. Pharm., 2013, 446, 112-118.
51. Paciotti, G. F.; Kingston, D. G. I.; Tamarkin, L. Colloidal gold nanoparticles: A novel nanoparticle platform for developing multifunctional tumor-targeted drug delivery vectors. Drug Develop. Res., 2006, 67, 47-54.
52. Kingston, D. G. I.; Cao, S.; Zhao, J.; Paciotti, G. F.; Hubta, M. S. Patent No.: US 8,558,019 B2, Date of Patent: Oct. 15, 2013.
53. Podsiadlo, P.; Sinani, V. A.; Bahng, J. H.; Kam, N. W. S.; Lee, J.; Kotov, N. A. Gold nanoparticles enhance the anti-leukemia action of a 6-mercaptopurine chemotherapeutic agent. Langmuir, 2008, 24, 568-574.
54. Rica, R.; Aili, D.; Stevens, M. M. Enzyme-responsive nanoparticles for drug release and diagnostics. Adv. Drug Deliv. Rev., 2012, 64, 967-978.
55. Andresen, T. L.; Thompson, D. H.; Kaasgaard, T. Enzymetriggered nanomedicine: Drug release strategies in cancer therapy. Mol. Membr. Biol., 2010, 27, 353-63.
56. Hwu, J. R.; Lin, Y. S.; Josephrajan, T.; Hsu, M. H.; Cheng, F. Y.; Yeh, C. S.; Su, W. C.; Shieh, D. B. Targeted paclitaxel by conjugation to iron oxide and gold nanoparticles. J. Am. Chem. Soc., 2008, 131, 66-68.
57. Schwert, G. W.; Eisenberg, M. A. The kinetics of the amidase and esterase activities of trypsin. J. Biol. Chem., 1949, 179, 665-672.
58. Gibson, J. D.; Khanal, B. P.; Zubarev, E. R. Paclitaxelfunctionalized gold nanoparticles. J. Am. Chem. Soc., 2007, 129, 11653-11661.
59. Kumar, S. A.; Peter, Y. A.; Nadeau, J. L. Facile biosynthesis, separation and conjugation of gold nanoparticles to doxorubicin. Nanotechnology, 2008, 19, 495101.
60. Zhang, X.; Chibli, H.; Mielke, R.; Nadeau, J. Ultrasmall gold-Doxorubicin conjugates rapidly kill apoptosis-resistant cancer cells. Bioconjugate Chem., 2011, 22, 235-243.
61. Chen, H.; Li, B.; Ren, X.; Li, S.; Ma, Y.; Cui, S.; Gu, Y. Multifunctional near-infrared-emitting nano-conjugates based on gold clusters for tumor imaging and therapy. Biomaterials, 2012, 33, 8461-8476.
62. Dhar, S.; Daniel, W. L.; Giljohann, D. A.; Mirkin, C. A.; Lippard, S. J. Polyvalent oligonucleotide gold nanoparticle conjugates as delivery vehicles for Platinum(IV) warheads. J. Am. Chem. Soc., 2009, 131, 14652-14653.
63. Gao, W.; Chan, J. M.; Farokhzad, O. C. pH-responsive nanoparticles for drug delivery. Mol. Pharm., 2010, 7, 1913-1920.
64. Vaupel, P. Tumor microenvironmental physiology and its implications for radiation oncology. Semin. Radiat. Oncol., 2004, 14, 198- 206.
65. Murphy, R. F.; Powers, S.; Cantor, C. R. Endosome pH measured in single cells by dual fluorescence flow cytometry: Rapid acidification of insulin to pH 6. J. Cell. Biol., 1984, 98, 1757-1762.
66. Akinc, A.; Thomas, M.; Klibanov, A. M.; Langer, R. Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis. J. Gene Med., 2005, 7, 657-663.
67. Bae, Y.; Fukushima, A.; Harada, A.; Kataoka, K. Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: Polymeric micelles that are responsive to intracellular pH change. Angew. Chem. Int. Ed., 2003, 42, 4640-4643.
68. Aryal, S.; Grailer, J. J.; Pilla, S.; Steeber, D. A.; Gong, S. Doxorubicin conjugated gold nanoparticles as water-soluble and pHresponsive anticancer drug nanocarriers. J. Mater. Chem., 2009, 19, 7879-7884.
69. Wang, F.; Wang, Y. C.; Dou, S.; Xiong, M.-H.; Sun, T.-M.; Wang, J. Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells. ACS Nano., 2011, 5, 3679-3692.
70. McCoy, C. P.; Rooney, C.; Edwards, C. R.; Jones, D. S.; Gorman, S. P. Light-triggered molecule-scale drug dosing devices. J. Am. Chem. Soc., 2007, 129, 9572-9573.
71. Mayer, G.; Heckel, A. Biologically active molecules with a "light switch". Angew. Chem. Int. Ed., 2006, 45, 4900-4921.
72. Dreaden, E. C.; Mackey, M. A.; Huang, X.; Kang, B.; El-Sayed, M. A. Beating cancer in multiple ways using nanogold. Chem. Soc. Rev., 2011, 40, 3391-3404.
73. Dickerson, E. B.; Dreaden, E. C.; Huang, X. H.; El-Sayed, I. H.; Chu, H. H.; Pushpanketh, S.; McDonald, J. F.; El-Sayed, M. A. Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice. Cancer Lett., 2008, 269, 57-66.
74. Hribar, K. C.; Metter, R. B.; Ifkovits, J. L.; Troxler, T.; Burdick, J. A. Light-induced temperature transitions in biodegradable polymer and nanorod composites. Small, 2009, 5, 1830-1834.
75. You, J.; Zhang, R.; Zhang, G. Photothermal-chemotherapy with doxorubicin-loaded hollow gold nanospheres: A platform for nearinfrared light-trigged drug release. J. Control. Release, 2012, 158, 319-328.
76. Troutman, T. S.; Leung, S. J.; Romanowski, M. Light-induced content release from plasmon-resonant liposomes. Adv. Mater., 2009, 21, 2334-2338.
77. Paasonen, L.; Sipilä, T.; Subrizi, A.; Laurinmäki, P.; Butcher, S. J.; Rappolt, M.; Yaghmur, A.; Urtti, A.; Yliperttula, M. Goldembedded photosensitive liposomes for drug delivery: Triggering mechanism and intracellular release. J. Control. Release, 2010, 147, 136-143.
78. Han, G.; You, C.-C.; Kim, B.-J.; Turingan, R. S.; Forbes, N. S.; Martin, C. T.; Rotello, V. M. Light-regulated release of DNA and its delivery to nuclei by means of photolabile gold nanoparticles. Angew. Chem. Int. Ed., 2006, 45, 3165 -3169.
79. Agasti, S. S.; Chompoosor, A.; You, C.-C.; Ghosh, P.; Kim, C. K.; Rotello, V. M. Photoregulated release of caged anticancer drugs from gold nanoparticles. J. Am. Chem. Soc., 2009, 131, 5728-5729.
80. Alcantar, N. A.; Aydil, E. S.; Israelachvili, J. N. Polyethylene glycol-coated biocompatible surfaces. J. Biomed. Mater. Res., 2000, 51(3), 343-351.
81. Han, G.; Chari, N. S.; Verma, A.; Hong, R.; Martin, C. T.; Rotello, V. M. Controlled recovery of the transcription of nanoparticlebound DNA by intracellular concentrations of glutathione. Bioconjugate Chem., 2005, 16, 1356-1359.
82. Gu, Y. J.; Cheng, J.; Man, C. W. Y.; Wong, W. T.; Cheng, S. H. Gold-doxorubicin nanoconjugates for overcoming multidrug resistance. Nanomedicine, 2012, 8, 204-211.
83. Ding, Y.; Zhou, Y. Y.; Chen, H.; Geng, D. D.; Wu, D. Y.; Hong, J.; Shen, W. B.; Hang, T. J.; Zhang, C. The performance of thiolterminated PEG-paclitaxel-conjugated gold Nanoparticles. Biomaterials, 2013, 34, 10217-10227.
84. Jong, W. H. D.; Hagens, W. I.; Krystek, P.; Burge, M. C.; Sips, A. J. A. M.; Geertsma, R. E. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials, 2008, 29, 1912-1919.
85. Jenkin, C. R.; Rowley, D. The role of opsonins in the clearance of living and inert particles by cells of the reticuloendothelial system. J. Experimental Med., 1961, 114(3), 363-374.
86. Saba, T. M. Physiology and physiopathology of the reticuloendothelial system. Arch. Intern. Med., 1970, 126(6), 1031-1052.
87. Khlebtsov, N.; Dykman, L. Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. Chem. Soc. Rev., 2011, 40, 1647-1671.
88. Maeda, H.; Wu, J.; Sawa, T.; Matsumura, Y.; Hori, K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control. Release, 2000, 65, 271-284.
89. Jain, R. K.; Stylianopoulos, T. Delivering nanomedicine to solid tumors. Nat. Rev. Clin. Oncol., 2010, 7, 653-664.
90. Wang, B.; He, X.; Zhang, Z.; Zhao, Y.; Feng. W. Metabolism of nanomaterials in vivo: Blood circulation and organ clearance. Acc. Chem. Res., 2013, 46(3), 761-769.
91. Sadauskas, E.; Danscher, G.; Stoltenberg, M.; Vogel, U.; Larsen, A.; Wallin, H. Protracted elimination of gold nanoparticles from mouse liver. Nanomedicine, 2009, 5, 162-169.
92. Lewinski, N.; Colvin, V.; Drezek, R. Cytotoxicity of nanoparticles. Small, 2008, 4(1), 26-49.
93. Sharifi, S.; Behzadi, S.; Laurent, S.; Forrest, M. L.; Stroevee. P.; Mahmoudi, M. Toxicity of nanomaterials. Chem. Soc. Rev., 2012, 41, 2323-2343.
94. Alkilany, A. M.; Murphy, C. J. Toxicity and cellular uptake of gold nanoparticles: what we have learned so far? J. Nanopart. Res., 2010, 12, 2313-2333.
95. Trana, N. T. T.; Wang, T.-H.; Lin, C.-Y.; Tai, Y. Synthesis of methotrexate-conjugated gold nanoparticles with enhanced cancer therapeutic effect. Biochem. Eng. J., 2013, 78, 175- 180.
96. Kim, S. T.; Saha, K.; Kim, C.; Rotello, V. M. The role of surface functionality in determining nanoparticle cytotoxicity. Acc. Chem. Res., 2013, 46(3), 681-691.
97. Cho, E. C.; Xie, J. W.; Wurm, P. A.; Xia, Y. N. Understanding the role of surface charges in cellular adsorption versus internalization by selectively removing gold nanoparticles on the cell surface with a I2/KI etchant. Nano Lett., 2009, 9, 1080-1084.
98. Chompoosor, A.; Han, G.; Rotello, V. M. Charge dependence of ligand release and monolayer stability of gold nanoparticles by biogenic thiols. Bioconjug. Chem., 2008, 19(7), 1342-1345.
99. Ghosh, P. S.; Kim, C. K.; Han, G.; Forbes, N. S.; Rotello, V. M. Efficient gene delivery vectors by tuning the surface charge density of amino acid-functionalized gold nanoparticles. ACS Nano., 2008, 2(11), 2213-2218.
100. Tatur, S.; Maccarini, M.; Barker, R.; Nelson, A.; Fragneto, G. Effect of functionalized gold nanoparticles on floating lipid bilayers. Langmuir, 2013, 29, 6606-6614.
101. Fröhlich, E. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Inter. J. Nanomed., 2012, 7, 5577-5591.
102. Kommareddy, S.; Amiji, M. Poly(ethyleneglycol)-modi ed thiolated gelatin nanoparticles for glutathione-responsive intracellular DNA delivery. Nanomedicine, 2007, 3(1), 32-42.
103. Shenoy, D.; Fu, W.; Li, J.; Crasto, C.; Jones, G.; DiMarzio, C.; Sridhar, S.; Amiji, M. Surface functionalization of gold nanoparticles using hetero-bifunctional poly(ethylene glycol) spacer for intracellular tracking and delivery. Int. J. Nanomedicine, 2006, 1, 51- 57.
104. Sudimack, J.; Lee, R. J. Targeted drug delivery via the folate receptor. Adv. Drug Deliv. Rev., 2000, 41(2), 147-162.
105. Lu, Y.; Low, P. S. Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv. Drug Deliv. Rev., 2002, 54(5), 675-693.
106. Manju, S.; Sreenivasan, K. Gold nanoparticles generated and stabilized by water soluble curcumin-polymer conjugate: Blood compatibility evaluation and targeted drug delivery onto cancer cells. J. Colloid Interf. Sci., 2012, 368, 144-151.
107. Chen, H.; Li, S.; Li, B.; Ren, X.; Li, S.; Mahounga, D. M.; Cui, S.; Gu, Y.; Achilefu, S. Folate-modified gold nanoclusters as nearinfrared fluorescent probes for tumor imaging and therapy. Nanoscale., 2012, 4(19), 6050-6064.
108. Kempson, I. M.; Chien, C. C.; Chung, C. Y.; Hwu, Y.; Paterson, D.; de Jonge, M. D.; Howard, D. L. Fate of intravenously administered gold nanoparticles in hair follicles: follicular delivery, pharmacokinetic interpretation, and excretion. Adv. Healthc. Mater., 2012, 1(6), 736-741.
109. Roa, W.; Xiong, Y.; Chen, J.; Yang, X.; Song, K.; Yang, X.; Kong, B.; Wilson, J.; Xing, J. Z. Pharmacokinetic and toxicological evaluation of multi-functional thiol-6-fluoro-6-deoxy-d-glucose gold nanoparticles in vivo. Nanotechnology, 2012, 23(37), 375101.